News
Stories and articles featuring PCI, our partners, and Penn-affiliated spinout companies
Stories and articles featuring PCI, our partners, and Penn-affiliated spinout companies
This fall, the Penn Center for Innovation and Penn Medicine present three monthly speaker sessions with experts in the field of Life Sciences investing, university startups, and intellectual property.
iEcure raised $65 million to advance its in vivo gene-editing technology aimed at treating rare pediatric liver diseases.
The trial will recruit participants from a pool of Penn Medicine employees whose responses to the PennOpen Pass screening system indicate that they may be infected with COVID-19.
The Wilcox Lab selects and tests different materials for effective mineral carbonation. The team also compares CO2 uptake based on exterior conditions like air temperature and humidity.
Their innovative work was recognized by the Philadelphia Business Journal's PHL Inno initiative, which awards people 25 years and younger who are making an impact in the area’s startup ecosystem.
This year, the University of Pennsylvania ranked particularly high in the research category, coming in at number two, second only to Massachusetts Institute of Technology (MIT).
Feredun Azari, M.D., Sardar Azari, and Sunil Singhal, M.D., co-invented OptiDx, an AI-powered optical tool for fluorescence-guided oncological surgery.
The hope is that this new technology could simplify the process of CAR-T cell therapy and make gene therapy widely available as a one-time injection to a much larger number of patients.
The University of Pennsylvania (Penn) Telehealth Research Center in Cancer Care (Penn TRACE) will become one of four NCI Telehealth Research Centers of Excellence.
The Pennovation Accelerator, an annual six week program that teaches local startups about business development, held their fifth annual Pitch Day at the Pennovation Center.